Earnings Release • May 18, 2021
Earnings Release
Open in ViewerOpens in native device viewer

Bilfinger SE
May 11, 2021
| Markets | • Increase in activity level • Remaining COVID restrictions in single areas, esp. North Sea upstream |
|---|---|
| -1% org. Orders received |
• With €1bn on good level • E&M Europe robust, sizeable project in North America won |
| -5% org. Revenue |
• Below prior-year which was still largely unaffected by COVID-19 • E&M Europe and Technologies on solid level • E&M International project business in line with expectations, however, still modest |
| €11 million EBITA adjusted |
• Clearly positive, structural improvements and reduced cost base show effect • Lower seasonality effects due to higher cost agility |
| -€28 million Free cash flow reported |
• Significant improvement against prior-year quarter • Limited capital consumption thanks to active working capital management |
| Outlook 2021 confirmed |
• Revenue: Significant growth • EBITA adjusted level of 2019 (2.4%), despite significantly lower revenue |

| Industries | %* | Overall trend |
||
|---|---|---|---|---|
| Chemicals & Petrochem |
40% | • Market starts to recover • Majority of large investments still planned to take place • Deferred work/shutdowns expected to raise activity levels in 2021/22 |
||
| Energy & Utilities |
10% | • ESG climate change drivers still hold, e.g. CO limits, emissions, 2 decentralized power generation • Green energy investment projects emerging as anticipated (e.g. renewables, hydrogen, carbon capture etc.) |
||
| Oil & Gas | 20% | • Consolidation of supplier market • OpEx stabilized after initial shock and gradual recovery foreseen • Recovery supported by asset integrity/shutdowns related backlog plus older asset life extensions |
||
| * % of segment revenues FY 2020 |
| Industries | %* | Overall trend |
|
|---|---|---|---|
| Chemicals & Petrochem |
20% | • Trend for expansion and modernization projects in ME intact • Attractive project pipeline in NA emerging |
|
| Energy & Utilities |
10% | • Continued growth in ME population and industry drives further development of alternative and nuclear energy concepts as well as water solutions • In NA, more positive outlook for energy investment focused on renewables and impetus from public spent (American Rescue Plan) |
|
| Oil & Gas | 25% | • Large oil & gas and LNG investment plans in several ME countries (e.g. UAE, Qatar, Kuwait) for the upcoming years • CAPEX and OPEX spend expected to increase from 2021 onwards in NA |
| Industries | %* | Overall trend |
|
|---|---|---|---|
| Energy & Utilities |
40% | • Energy transition focus in all our regions, esp. Europe and NA • Nuclear demand for new builds and maintenance increasing, esp. in France, UK, Finland and demand increasing for decommissioning in Germany |
|
| Pharma & Biopharma |
35% | • Mega trends remain unchanged despite COVID-19 • Positive outlook on Pharma OPEX; Trend to outsource services and production is increasing |
No LTI since May 2017
Installation of pumps, compressors, towers, vessels and equipment as well as E&I services
Heat Efficiency Program at Shell Moerdijk
5-year program
Improvement of energy efficiency

• 9% above prior-year level (org.: +11%), also above end of year 2020 level
• Solid at 1.2

• -9% (org.: -5%) below prior-year quarter, which was still largely unaffected by COVID-19 at the time
• Significant reduction to -€2 million (prior year: -€9 million)

Adjustments Reported

• €16m (prior year: €4m) significant increase due to agile cost management

Revenue: significant growth


• Decrease of -33% (org.: -28%), strategic measures and several sales initiatives introduced
• -€5m (prior year: -€1m)

Revenue: significant growth
EBITA adjusted: significant improvement to a positive result

• -60% (org.: -59%), exceptionally high order intake in prior-year quarter including Hinkley Point C
• +16% (org.: +18%) underpins growth aspiration in this segment
• €3m (prior year: -€5m), continuing the encouraging trend seen in second half of 2020
Revenue: significant growth

EBITA adjusted: significant improvement to a clearly positive result
-93 -28 -80 -6 Q1 2020 Q1 2021 Adjusted FCF Reported FCF Net profit 1) (€ million) -24 10 -13 4 Q1 2020 Q1 2021 Reported Net Profit Adjusted Net Profit Free cash flow 1) (€ million)
1) Adjustments correspond to EBITA adjustments, Net Profit: in addition elimination of special items in financial result and in taxes


| 3m 2021 excl. IFRS 16 |
IFRS 16 impacts |
3m 2021 incl. IFRS 16 |
3m 2020 excl. IFRS 16 |
|
|---|---|---|---|---|
| EBITA adj. | 11 | 11 | -11 | |
| Depreciation | 11 | 13 | 24 | 13 |
| Change in NWC (Reported) | -50 | -50 | -103 | |
| Others | -31 | -31 | -9 | |
| Adjustments | 23 | 23 | 12 | |
| Operating CF Reported | -36 | -23 | -98 | |
| Net CAPEX | -5 | -5 | - g | |
| Free CF Reported | -41 | -28 | -107 | |
| Proceeds/Investments financial assets | -3 | -3 | 3 | |
| Changes in marketable securities | 0 | 0 | 0 | |
| Dividends | 0 | 0 | 0 | |
| Change in financial debt | 0 | -12 | -12 | 0 |
| Interest paid | -1 | -1 | -2 | -1 |
| FX / other / disco | -2 | -2 | -3 | |
| Change in Cash | -47 | -47 | -108 |

1) Including IFRS 16 leases DSO: Trade receivables + WIP – advance payments received, DPO: Trade payables
| Actual FY 2020 | Outlook FY 2021 | |
|---|---|---|
| Revenue | €3,461 million | Significant growth |
| EBITA adjusted | €20 million | Substantial improvement |
| Free cash flow reported |
€93 million | Positive, but below prior-year |
Underlying assumptions:
Quarterly Statement Q1 2021 Financial backup
| E&M Europe | Reconciliation Group |
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E&M International | Technologies | HQ / Consolidation / Other |
OOP | Group | ||||||||||||||
| € million | Q1 2021 |
Q1 2020 |
Δ in % | Q1 2021 |
Q1 2020 |
Δ in % | Q1 2021 |
Q1 2020 |
Δ in % | Q1 2021 |
Q1 2020 |
Δ in % | Q1 2021 |
Q1 2020 |
Δ in % | Q1 2021 |
Q1 2020 |
Δ in % |
| Orders received | 675 | 631 | +7% | 161 | 154 | +4% | 115 | 287 | -60% | -3 | -78 | +96% | 53 | 65 | -18% | 1,001 | 1,060 | -5% |
| Order backlog |
1,840 | 1,516 | +21% | 391 | 456 | -14% | 550 | 542 | +2% | -75 | -82 | +10% | 89 | 130 | -31% | 2,796 | 2,562 | +9% |
| Revenue | 561 | 573 | -2% | 110 | 165 | -33% | 130 | 113 | +16% | -13 | -2 | -499% | 45 | 67 | -33% | 833 | 915 | -9% |
| Investments in P,P&E |
8 | 6 | +24% | 0 | 1 | -82% | 0 | 1 | -13% | 0 | 1 | -95% | 0 | 1 | -87% | 8 | 9 | -9% |
| Increase in right-of use assets |
7 | 7 | -6% | 0 | 1 | -72% | 0 | 1 | -90% | 0 | 0 | n/a | 0 | 0 | n/a | 7 | 10 | -26% |
| Depreciation | -16 | -16 | -1% | -2 | -3 | +25% | -2 | -2 | +3% | -3 | -4 | +16% | -1 | -2 | +59% | -24 | -27 | +9% |
| Amortization | 0 | 0 | n/a | 0 | -1 | +100% | 0 | 0 | n/a | 0 | 0 | n/a | 0 | 0 | n/a | 0 | -1 | +100% |
| EBITDA adjusted | 32 | 20 | +65% | -3 | 2 | - | 5 | -3 | - | -1 | -4 | +78% | 1 | 1 | -7% | 35 | 16 | +117% |
| EBITA | 16 | 1 | +2649% | -7 | -4 | -58% | 4 | -5 | - | -4 | -10 | +58% | 0 | -1 | +134% | 9 | -20 | - |
| EBITA adjusted | 16 | 4 | +336% | -5 | -1 | -290% | 3 | -5 | - | -4 | -7 | +46% | 0 | -1 | +134% | 11 | -11 | - |
| EBITA-margin adjusted |
2.9% | 0.7% | -4.7% | -0.8% | 2.4% | -4.3% | 30.0% | 331.6% | 0.7% | -1.3% | 1.3% | -1.2% |

| Q1 | |||||
|---|---|---|---|---|---|
| in € million | 2021 | 2020 | Δ in % | ||
| Revenue | 833 | 915 | -9% | ||
| Gross profit | 79 | 67 | 18% | ||
| Selling and administrative expense |
-70 | -86 | 19% | ||
| Impairment losses and reversal of impairment losses according to IFRS 9 |
-2 | -1 | -100% | ||
| Other operating income and expense | 1 | -7 | - | ||
| Income from investments accounted for using the equity method |
1 | 6 | -83% | ||
| EBIT | 9 | -21 | - | ||
| Amortization of intangible assets from acquisitions and impairment of goodwill |
0 | 1 | 100% | ||
| EBITA (for information only) | 9 | -20 | - | ||
| Special items in EBITA | 2 | 9 | -78% | ||
| EBITA adjusted (for information only) |
11 | -11 | - |

| Q1 | |||
|---|---|---|---|
| in € million |
2021 | 2020 | Δ in % |
| EBIT | 9 | -21 | - |
| Financial result |
2 | -7 | - |
| EBT | 11 | -27 | - |
| Income taxes | 0 | 4 | -100% |
| Earnings after taxes from continuing operations |
11 | -23 | - |
| Earnings after taxes from discontinued operations |
-1 | -1 | 0% |
| Minority interest | 0 | 0 | 0% |
| Net profit |
10 | -24 | - |
| Adjusted net profit1) | 4 | -13 | - |
| Average number of shares (in thousands) |
40,430 | 40,291 | |
| Earnings per share (in €) | 0.26 | -0.60 | |
| thereof from continuing operations | 0.27 | -0.58 | |
| thereof from discontinued operations 1) from continuing operations |
-0.01 | -0.02 |
| in € million | Q1 2020 | Q2 2020 | Q3 2020 | Q4 2020 | FY 2020 | Q1 2021 |
|---|---|---|---|---|---|---|
| EBITA | -20 | -51 | 0 | 14 | -57 | 9 |
| Disposal losses/gains, write-downs, selling-related expenses |
0 | 2 | 3 | -1 | 4 | 0 |
| Compliance | 0 | -17 | 0 | 0 | -17 | 0 |
| Restructuring, extraordinary depreciations |
6 | 28 | 18 | 25 | 77 | 1 |
| IT investments | 3 | 3 | 3 | 4 | 13 | 1 |
| Total adjustments | 9 | 16 | 24 | 28 | 77 | 2 |
| EBITA adjusted | -11 | -35 | 23 | 42 | 20 | 11 |

Goodwill increases to 774 (12/20: 761) due to currency effects.
Non-current assets include property, plant and equipment 265, according to IFRS 16 right-of-use assets from leases 184, deferred tax assets 56.
Current assets: receivables 465 (12/20: 505).
Marketable assets include PPN Apleona.
In Q1 2021, slight increase in equity due to positive earnings after taxes, equity ratio at level of prior quarter.
Pension provisions: decrease due to increase in Euro interest rate from 0.7% to 1.0%.
Financial debt relates to Bond 06/2024 with 250, SSD with 123 and leases with 191.
Current liabilities relates mainly to liabilities of 833 (12/20: 800), including 306 (12/20: 293) from payables and 135 from advance payments received, and other accruals of 267 (12/20: 300).
| € million | March 31, 2021 |
December 31, 2020 |
March 31, 2020 |
|---|---|---|---|
| Non-current assets | |||
| Intangible assets | 777.9 | 765.2 | 791.0 |
| Property, plant and equipment | 265.2 | 269.7 | 302.9 |
| Right-of-use assets from leases | 183.7 | 189.3 | 216.3 |
| Investments accounted for using the equity method | 20.1 | 19.4 | 22.1 |
| Other financial assets | 11.5 | 14.0 | 255.0 |
| Deferred taxes | 55.6 | 55.8 | 63.9 |
| 1,314.0 | 1,313.4 | 1,651.2 | |
| Current assets | |||
| Inventories | 65.1 | 59.8 | 61.2 |
| Receivables and other financial assets | 908.1 | 865.6 | 1,069.4 |
| Current tax assets | 18.4 | 10.9 | 15.6 |
| Other assets | 54.0 | 46.0 | 58.4 |
| Marketable securities | 457.1 | 450.0 | 0.0 |
| Cash and cash equivalents | 463.1 | 510.6 | 391.8 |
| Assets classified as held for sale | 0.0 | 0.0 | 0.0 |
| 1,965.8 | 1,942.9 | 1,596.4 | |
| Total | 3,279.8 | 3,256.3 | 3,247.6 |
| € million | March 31, 2021 |
December 31, 2020 |
March 31, 2020 |
|---|---|---|---|
| Equity | |||
| Equity attributable to shareholders of Bilfinger SE | 1,253.0 | 1,209.3 | 1,124.5 |
| Attributable to minority interest | -11.1 | -10.7 | -9.4 |
| 1,241.9 | 1,198.6 | 1,115.1 | |
| Non-current liabilities | |||
| Provisions for pensions and similar obligations | 322.2 | 340.0 | 325.9 |
| Other provisions | 21.2 | 22.2 | 23.4 |
| Financial debt | 519.5 | 521.3 | 541.5 |
| Other liabilities | 0.0 | 0.0 | 0.0 |
| Deferred taxes | 3.8 | 2.9 | 5.3 |
| 866.7 | 886.4 | 896.1 | |
| Current liabilities | |||
| Current tax liabilities | 24.3 | 23.9 | 24.5 |
| Other provisions | 267.3 | 300.3 | 291.9 |
| Financial debt | 46.4 | 46.9 | 49.2 |
| Trade and other payables | 604.0 | 579.2 | 661.3 |
| Other liabilities | 229.2 | 221.0 | 209.5 |
| Liabilities classified as held for sale | 0.0 | 0.0 | 0.0 |
| 1,717.2 | 1,171.3 | 1,236.4 | |
| Total | 3,279.8 | 3,256.3 | 3,247.6 |
| Q1 | ||
|---|---|---|
| in € million | 2021 | 2020 |
| Cash flow from operating activities of continuing operations | -22.9 | -84.0 |
| - Thereof special items |
-22.5 | -12.4 |
| - Adjusted cash flow from operating activities of continuing operations |
-0.4 | -71.6 |
| Net cash outflow for P,P&E and intangible assets | -5.3 | -8.6 |
| Free cash flow from continuing operations | -28.2 | -92.6 |
| - Thereof special items |
-22.5 | -12.4 |
| - Adjusted free cash flow from continuing operations |
-5.7 | -80.2 |
| Payments made / proceeds from the disposal of financial assets | -0.7 | 2.8 |
| Investments in financial assets | -1.9 | 0.0 |
| Changes in marketable securities | 0.0 | 0.0 |
| Cash flow from financing activities of continuing operations | -15.3 | -15.1 |
| - Share buyback |
0.0 | 0.0 |
| - Dividends |
0.0 | 0.0 |
| - Repayment of financial debt / borrowing |
-12.8 | -13.4 |
| - Interest paid |
-2.5 | -1.7 |
| Change in cash and cash equivalents of continuing operations |
-46.1 | -104.9 |
| Change in cash and cash equivalents of discontinued operations |
-1.9 | -2.1 |
| Change in value of cash and cash equivalents due to changes in foreign exchange rates | 0.5 | -1.0 |
| Change in cash and cash equivalents | -47.5 | -108.0 |
| Cash and cash equivalents at January 1 | 510.6 | 499.8 |
| Change in cash and cash equivalents of assets classified as held for sale |
0.0 | 0.0 |
| Cash and cash equivalents at March 31 |
463.1 | 391.8 |
| in € million | December 31, 2020 | March 31, 2021 |
|---|---|---|
| Cash, cash equivalents and marketable securities |
511 | 463 |
| Financial debt | -373 | -373 |
| / net debt (-) 1) Net cash (+) |
138 | 90 |
| Pension provisions | -340 | -322 |
| Financial assets (Apleona PPN / book value) | 450 | 457 |
| Future cash-out special items | approx. -70 | approx. -50 |
1) Without leasing liabilities of -190 (Mar. 31, 2021), -193 (Dec. 31,2020)
This presentation has been produced for support of oral information purposes only and contains forwardlooking statements which involve risks and uncertainties. Forward-looking statements are statements that are not historical facts, including statements about our beliefs and expectations. Such statements made within this document are based on plans, estimates and projections as they are currently available to Bilfinger SE. Forward-looking statements are therefore valid only as of the date they are made, and we undertake no obligation to update publicly any of them in light of new information or future events. Apart from this, a number of important factors could therefore cause actual results to differ materially from those contained in any forwardlooking statement. Such factors include the conditions in worldwide financial markets as well as the factors that derive from any change in worldwide economic development.
This document does not constitute any form of offer or invitation to subscribe for or purchase any securities. In addition, the shares of Bilfinger SE have not been registered under United States Securities Law and may not be offered, sold or delivered within the United States or to US persons absent registration under or an applicable exemption from the registration requirements of the United States Securities Law.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.